Archives

by in
Entry Author Date Location
Biogen Idec Boosts Biogenerics Strategy With $300M Samsung Joint Venture 12/06/11 Boston
Eli Lilly Pumps $4M into IDRI to Continue Hunt for TB Drugs 11/17/11 Seattle
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes 11/10/11 New York
Rhythm Adds Former Merck VP as CEO 11/09/11 Boston
Biopharma Industry Meetings Could Use Some Fresh Voices 11/01/11 Seattle
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs 10/27/11 San Francisco
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes 10/18/11 San Francisco
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M 10/17/11 San Diego
Stem Cell Therapy: A Process With a Promise 10/10/11 Seattle
Smoke on the Water: Fireworks at the Cleveland Clinic Medical Innovation Summit 10/10/11 San Francisco
When Will Software for the Genome Take Off? Find out Oct. 24 10/07/11 San Francisco
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
Lycera Hires New CEO, Plans Move to U-M Research Center 10/06/11 Detroit
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom 10/05/11 New York
Join Us for a Live ‘Tweetchat’ on the Future of RNAi, With Guest John Maraganore of Alnylam 09/28/11 National
Ambrx Grabs $24M Upfront in New Diabetes, Heart Failure Research Deal With Bristol-Myers 09/22/11 San Diego
Ariad Brings Third Cancer Drug Into Human Trials 09/22/11 Boston
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C 09/22/11 Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News 09/22/11 Seattle
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva 09/15/11 Seattle
Merck Joins the Big Pharma VC Party, Setting Up $250M Biotech Investment Fund 09/15/11 National
Theraclone Sniffs Around for $10M, Dendreon Gets Third Factory OK, Zymeworks’ Big Merck Deal, & More Seattle-Area Life Sciences News 09/08/11 Seattle
Marina Biotech Shuffles Management Team, as RNAi Falls Out of Favor, Cash Runs Low 09/07/11 Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk 08/29/11 Boston
Zymeworks Snags $187M Deal With Merck to Discover Multi-Pronged Antibodies 08/29/11 Seattle
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine 08/17/11 National
Page 2 of 12 « previous page · next page »
    

Xconomy Events Across the Network

The Napa Summit: Keeping America Growing

San Francisco · 6/7/12

More Xconomy Events

Xconomy’s Most Popular

  1. ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
  2. Biotech IPOs Start to Show Some Modest Signs of Life
  3. Hey, Silicon Valley: Wake Up and Smell the Robots
  4. From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
  5. Announcing Xconomy’s Napa Summit: Keeping America Growing

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.